Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
J Natl Cancer Inst. 2015 Feb 6;107(3):dju509. doi: 10.1093/jnci/dju509. Print 2015 Mar.
J Natl Cancer Inst. 2015.
PMID: 25663690
No abstract available.
Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy.
Adhikaree J, Newby Y, Sundar S.
Adhikaree J, et al. Among authors: newby y.
BMJ Case Rep. 2014 Jan 30;2014:bcr2013202861. doi: 10.1136/bcr-2013-202861.
BMJ Case Rep. 2014.
PMID: 24481018
Free PMC article.
Item in Clipboard
Cite
Cite